Should I buy or sell Bachem stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bachem in the last year. There are currently 2 sell ratings for the stock. The consensus among Wall Street analysts is that investors should "sell" BCHMF shares. View BCHMF analyst ratings or view top-rated stocks .

How have BCHMF shares performed in 2023?

Bachem's stock was trading at $84.4754 at the beginning of 2023. Since then, BCHMF shares have increased by 0.0% and is now trading at $84.4754. View the best growth stocks for 2023 here .

Are investors shorting Bachem?

Bachem saw a increase in short interest in November. As of November 15th, there was short interest totaling 271,600 shares, an increase of 7.9% from the October 31st total of 251,800 shares. Based on an average trading volume of 100 shares, the short-interest ratio is currently 2,716.0 days. View Bachem's Short Interest .

How do I buy shares of Bachem?

Shares of BCHMF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull , Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here .

Bachem Stock Price, News & Analysis (OTCMKTS:BCHMF)

$84.48

0.00 (0.00%)

(As of 11/1/2023)

Compare

Today's Range: $84.48
▼
$84.48
50-Day Range: $84.48
▼
$84.48
52-Week Range: $84.90
▼
$84.90

Volume: 215 shs
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Analyst Forecasts Chart Short Interest

About Bachem Stock (OTCMKTS:BCHMF)

Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. The company engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). It also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, and supply and vertical integration services. The company was founded in 1971 and is headquartered in Bubendorf, Switzerland.

BCHMF Stock Price History

30 days | 90 days | 365 days | Advanced Chart

BCHMF Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Receive BCHMF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bachem and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Chemicals
Sub-Industry: N/A
Sector: Basic Materials
Current Symbol: OTCMKTS:BCHMF
CUSIP: N/A
CIK: N/A
Web: www.bachem.com
Phone: 41-58-595-2021
Fax: N/A
Employees: 1,926
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

Beginners Guide To Retirement Stocks

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

Mr. Thomas Meier (Age 55)
CEO, COO & Chairman of Group Executive Board
Comp: $602.05k
Mr. Alain Schaffter (Age 46)
Chief Financial Officer
Mr. Michael Suter
Vice President of Global Accounting
Dr. Gunther Loidl (Age 53)
Chief Technology Officer
Mr. Achim Pluckebaum
Chief Information Officer
Dr. Daniel Grotzky
Head of Group Communications
Viviane Minden
Chief Human Resources Officer
Dr. Anne-Kathrin Stoller Ph.D. (Age 49)
Chief Operating Officer of Bachem Americas, Inc.
Dr. Torsten Wohr (Age 55)
Chief Commercial Officer
Mr. Boris Corpataux
VP & Head Global Strategic Alliances

Key Competitors

View All Competitors

BCHMF Stock Analysis - Frequently Asked Questions

Should I buy or sell Bachem stock right now?: 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bachem in the last year. There are currently 2 sell ratings for the stock. The consensus among Wall Street analysts is that investors should "sell" BCHMF shares.
View BCHMF analyst ratings or view top-rated stocks.
How have BCHMF shares performed in 2023?: Bachem's stock was trading at $84.4754 at the beginning of 2023. Since then, BCHMF shares have increased by 0.0% and is now trading at $84.4754.
View the best growth stocks for 2023 here.
Are investors shorting Bachem?: Bachem saw a increase in short interest in November. As of November 15th, there was short interest totaling 271,600 shares, an increase of 7.9% from the October 31st total of 251,800 shares. Based on an average trading volume of 100 shares, the short-interest ratio is currently 2,716.0 days.
View Bachem's Short Interest.
How do I buy shares of Bachem?: Shares of BCHMF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (OTCMKTS:BCHMF) was last updated on 12/6/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial